BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.

BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT)
Listen to this Section


$7.64
-0.0500 ( -0.65% ) 312.6K

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Market Data


Open $7.64
Previous Close $7.69
Volume 312.6K
Market Cap $616.02M
Day Range $7.39 - $8.00
52 Week Range $7.00 - $14.87
Shares Outstanding 80.11M
Change % -0.65%
Net Change ▼ -0.0500
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2025
CountryUnited States
UnderwriterLeerink Partners, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 12, 2025
10-q Quarterly Reports 82 Nov 12, 2025

Latest News